Close on the heels of global pharmaceutical major Lonza announcing its plans to invest $150 million (Rs 750 crore), Alexandria – a provider of lab space – has said it would invest around $200 million (Rs 1,000 crore) in Genome Valley, Hyderabad, in a phased manner.
The US-based life science infrastructure giant would create plug-and-play lab space to cater to the needs of domestic and international biotech and pharmaceutical companies, said BP Acharya, Chairman and Managing Director, Andhra Pradesh Industrial Infrastructure Corporation (APIIC) at the ‘India Evening’ programme held in Atlanta during the Biotech Industry Organisation conference two days ago.
